Author: ___

  • Cancer and the Gut: How Bacteria Could Improve Responses to Immunotherapy

    Cancer and the Gut: How Bacteria Could Improve Responses to Immunotherapy

    Rachel Lim ‘29 In 1863, German physician Rudolf Virchow, “the father of modern pathology,” observed the increased presence of white blood cells in abnormal tissue growth and was the first to propose the relationship between immune function and cancer. From the 1890s to the 1930s, doctors observed that some bacterial infections caused tumors to shrink.…

  • The New FDA-Approved Lung Cancer Drug 

    The New FDA-Approved Lung Cancer Drug 

    Vigneshwari Sivakumar ’29 Lung cancer is the nation’s deadliest cancer, affecting people of all backgrounds, with the most cases of 226,650 and deaths of 124,730 this year, according to the American Cancer Society (2025). Most cancers, when detected early, can be cured and treated; however, some studies show that even with earlier diagnosis, there is…

  • Lasso Peptides: A Promising New Antibiotic

    Lasso Peptides: A Promising New Antibiotic

    Vigneshwari Sivakumar ’29 Antibiotic resistance poses one of the most urgent challenges in modern medicine. However, recent work indicates that lasso peptides may hold promise for inhibiting multidrug-resistant bacterial pathogens. Maksimov et al. define lasso peptides as “a class of ribosomally synthesized posttranslationally modified natural products found in bacteria” (2012). The ‘lasso’ refers to their…